PerkinElmer

Medical Equipment
PKI
$ 137 (1.6)%
Share price
$ 17 bn
Market Cap
$ 21 bn
Enterprise Value

Carbon footprint

1.7 Ton
GHG emissions per $ 1 mln investment
0.04x the weighted average for S&P 500
FY2020
How is this calculated?
-8.8%
YOY change in GHG emissions
Weaker than the +4.2% weighted average for S&P 500
FY2020 vs. previous year

Primary Climate Goal

-2.3%
Proj. YOY change in GHG emissions (Scope 1 + 2)
Weaker than the -6.6% weighted average for S&P 500
FY2021
How is this calculated?

PerkinElmer aims to reduce Scope 1 + 2 by 30% by 2030 from a base year 2019


This target has not been verified as science based according to SBTi
PerkinElmer's actual and proj. GHG emissions (Scope 1 + 2) (Kt of CO2e)

GHG emissions and Carbon intensity

PerkinElmer's GHG emissions (market-based) (Kt of CO2e)

PerkinElmer's carbon footprint

PerkinElmer reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 35 Kt (-3.4 /-8.8% y-o-y).

PerkinElmer's Scope 3 emissions plummeted to 1.6 Kt (-6.2 /-79.9% y-o-y). This is a higher rate of decline than over the period since 4Q'18 (-52.7% CAGR).

The company is committed to reducing Scope 1 + 2 by 30% by 2030 from a base year 2019, which translates into the estimated reduction of -0.81 Kt per annum over the period of FY2021 - FY2030. This target, however, has not been recognised as science-based (and as aligned with Paris Agreement) by the SBTi.

Company environmental metrics

Show more...